Clinical Trial Update: Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab in patients with recurrent brain metastases who failed whole brain radiation therapy; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Northwestern University | Conditions: Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED | Results posted: 2019-04-25